Acurx Pharmaceuticals, Inc. (ACXP) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Acurx Pharmaceuticals, Inc. (ACXP) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

ACXP Income Statement

Acurx Pharmaceuticals, Inc. (ACXP) annual income statement — 7-year revenue, gross profit & net income history

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Sales/Revenue	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Revenue Growth %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Goods Sold	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
COGS % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	2.31M	1.72M	1.62M	2.03M	2.27M	2.15M	2.78M	2.82M	4.12M	4.38M	5.11M	3.11M	3.45M	2.9M	3.26M	3.54M	2.62M	2.67M	2.63M	4.64M
OpEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling, General & Admin	1.24M	1.37B	6.25B	1.6M	1.75M	1.55M	1.96M	1.62M	2.3M	2.82M	3.17M	1.77M	1.71M	1.89M	1.83M	1.95M	1.71M	1.85M	1.91M	3.52M
SG&A % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research & Development	1.07M	341.47K	1.83B	429.69K	524.21K	598.8K	825.06K	1.2M	1.83M	1.56M	1.94M	1.35M	1.74M	1.02M	1.43M	1.59M	911.69K	818.89K	716.22K	1.13M
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	0	-1000K	-1000K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Income	-2.31M	-1.72M	-1.62M	-2.03M	-2.27M	-2.15M	-2.78M	-2.82M	-4.12M	-4.38M	-5.11M	-3.11M	-3.45M	-2.9M	-3.26M	-3.54M	-2.62M	-2.67M	-2.63M	-4.64M
Operating Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-1.65%	20.16%	41.87%	28.1%	44.95%	50.91%	45.61%	9.42%	-19.66%	-50.81%	-56.86%	12.05%	-31.47%	-8.72%	-24.11%	23.71%	35.62%	-81.11%	-140.35%	-
EBITDA	-2.31M	-1.68M	-1.58M	-1.99M	-2.25M	0	0	0	-4.12M	-4.38M	0	0	0	-2.9M	0	0	0	-2.67M	0	0
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA Growth %	-2.71%	-	-	-	45.5%	100%	-	-	-	-50.81%	-	-	-	-8.72%	-	-	-	-	100%	-
D&A (Non-Cash Add-back)	0	0	0	0	0	2.15M	2.78M	2.82M	0	0	5.11M	3.11M	3.45M	0	3.26M	3.54M	2.62M	0	2.63M	4.64M
EBIT	-2.31M	-1.68M	-1.58M	-1.99M	-2.25M	-2.15M	-2.78M	-2.82M	-4.12M	-4.38M	-5.11M	-3.11M	-3.45M	-2.9M	-3.26M	-3.54M	-2.62M	-2.67M	-2.63M	-4.64M
Net Interest Income	53.05K	35.01K	38.84K	35.91K	23.4K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest Income	53.05K	35.01K	38.84K	35.91K	23.4K	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Income/Expense	53.05K	35.01K	38.84K	35.91K	23.4K	0	0	0	782	0	0	0	0	0	0	0	0	0	0	0
Pretax Income	-2.25M	-1.68M	-1.58M	-1.99M	-2.25M	-2.15M	-2.78M	-2.82M	-4.12M	-4.38M	-5.11M	-3.11M	-3.45M	-2.9M	-3.26M	-3.54M	-2.62M	-2.67M	-2.63M	-4.64M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income Tax	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Effective Tax Rate %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Net Income	-2.25M	-1.68M	-1.58M	-1.99M	-2.25M	-2.15M	-2.78M	-2.82M	-4.12M	-4.38M	-5.11M	-3.11M	-3.45M	-2.9M	-3.26M	-3.54M	-2.62M	-2.67M	-2.63M	-4.64M
Net Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-0.35%	21.79%	43.26%	29.37%	45.5%	50.91%	45.61%	9.42%	-19.64%	-50.81%	-56.86%	12.05%	-31.47%	-8.72%	-24.11%	23.71%	34.55%	-81.11%	-140.35%	-
Net Income (Continuing)	-2.25M	-1.68M	-1.58M	-1.99M	-2.25M	-2.15M	-2.78M	-2.82M	-4.12M	-4.38M	-5.11M	-3.11M	-3.45M	-2.9M	-3.26M	-3.54M	-2.62M	-2.67M	-2.63M	-4.64M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.53	-1.12	-0.67	-1.23	-1.89	-2.14	-3.27	-3.45	-5.21	-5.66	-7.60	-4.79	-5.60	-5.00	3.60	-6.40	-5.20	-5.20	-7.60	-9.20
EPS Growth %	71.96%	47.66%	79.51%	64.35%	63.72%	62.19%	56.97%	27.97%	6.96%	-13.2%	-311.11%	25.16%	-7.69%	3.85%	147.37%	30.43%	54.39%	-73.33%	-245.45%	-
EPS (Basic)	-0.53	-1.12	-0.67	-1.23	-1.89	-2.14	-3.27	-3.45	-5.21	-5.66	-7.60	-4.79	-5.60	-5.00	3.60	-6.40	-5.20	-5.20	-5.20	-9.20
Diluted Shares Outstanding	4.26M	1.5M	1.5M	1.63M	1.19M	1M	851.55K	818.15K	791.25K	773.65K	673.1K	650.25K	609.3K	581.95K	580.3K	557.4K	513.15K	511.65K	511.23K	505.8K
Basic Shares Outstanding	4.26M	1.5M	1.5M	1.63M	1.19M	1M	851.55K	818.15K	791.25K	773.65K	673.1K	650.25K	609.3K	581.95K	580.3K	557.4K	513.15K	511.65K	511.23K	505.8K
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-